Background: The need for products that treat or prevent urinary tract infections without resort to antibiotics that may select for resistant bacterial strains has created a need to develop antibiotic-free therapeutics. Objective: To conduct an exploratory evaluation of intrinsic antimicrobial activity of a panel of compounds alone or in combination against urinary pathogens and probiotic organisms as well as their effect on biofilm formation and immune activity in infected cultured bladder epithelial cells. Results: Of the compounds tested, 1% citric acid was most consistently inhibitory to urinary pathogens as were combinations containing citric acid. Two combinations of compounds were tested and both showed antimicrobial activity when challenged with 1 × 10 5 bacteria/mL. The two combination products and D-mannose did not inhibit probiotic microorganisms and one composition increased the inhibitory potential of probiotic organisms. Results obtained with biofilm studies were variable, but probiotic biofilm was enhanced under some circumstances. Biofilms of some urinary pathogens were reduced by antimicrobial mixtures. A strong cytokine response was elicited when T24 bladder epithelial cells were infected for one hour with urinary pathogens and a modest reduction in cytokine response was recorded with some combinations of test compounds. Conclusion: Citric acid alone and mixtures of various compositions containing citric acid inhibited the growth and biofilm formation by 4 uropathogens. Probiotic organisms grew in the presence of mannose and citric acid-containing combinations. One of the combinations enhanced probiotic activity of Lactobacilli against uropathogens. When infecting T24 cell monolayers with uropathogens, potential modulation of inflammatory activity was demonstrated.
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Introduction
Urinary tract infections are among the commonest of primary care issues accounting for millions of physician visits annually, and can range from asymptomatic to acute and may extend upward to involve the kidneys and spread beyond leading to sepsis and death in compromised individuals. Antibiotic treatment is standard but challenges and opportunities remain for progress in dealing with this prevalent medical problem including dosing or alternatives [1] . Antimicrobial pharmaceuticals may be limited either by antibiotic resistance or may select for antibiotic resistant strains. Recurrence of urinary infection with or without resistance development is concerning [2] and a growing number of patients have an interest in using natural products, which may be conveniently obtained over the counter. Interest in non-antibiotic approaches encompasses acute cystitis and prophylaxis of recurrent urinary infection [3] .
Current approaches to recurrent urinary infections in women have been described in detail in a recent review [4] and emphasize a more expansive approach to this problem than just focusing on antimicrobials. The role of physical concerns such as anatomic anomalies, or urinary calculi, behavioral components of risk and lack of meta data support for some non-antibiotic approaches, lead ultimately to the presentation of a selection of antibiotic agents that are used for prophylaxis or intermittent treatment. Thus, it appears that antibiotics will retain a role for the time being despite the fact that clinicians are increasingly cautious about their overuse.
Beerpoot and co-workers [5] [6] provided reviews of clinical uses of non-antibiotic approaches to urinary prophylaxis, mentioning various categories of intervention including vaccination, probiotic Lactobacillus, estriol and cranberry. Mannose has support from basic and clinical studies as a bacterial adherence-blocking reagent [7] [8] [9] but a Latin American consensus group indicated mannose has less research support than bacterial lysates or local estrogen [10] . Numerous other, less studied, examples lack confirmation of efficacy [11] .
Presented here are preclinical findings using a panel of compounds alone or in combination to inhibit urinary pathogens. Combinations of these compounds were selected based on anticipated potential usefulness in acute cystitis or prophylaxis against recurrent infection. However, these combinations were not marketed therapeutics. Of interest were bacterial growth, bacterial biofilm formation and possible immune reactions in the bladder.
Methods
The laboratory work described here was conducted at the Marian University Open Journal of Obstetrics and Gynecology College of Osteopathic Medicine between January and May of 2019.
Microorganisms
All bacterial isolates used in this study were obtained from American Type Culture Collection and regardless of their original source, should be considered as laboratory strains because they were not recently in a human host. Specifically, these included E. coli ATCC 11775 [12] , Proteus mirabilis ATCC 7002 [13] , Streptococcus agalactiae ATCC13813 [14] and Enterococcus faecalis ATCC19433 [15] .
Probiotic microorganisms were from frozen laboratory stocks and included the following Lactobacillus species: crispatus, gasseri, jensenii, and rhamnosis as well as Saccharomyces boulardii. All cultures were stored at −80˚C and grown overnight in brain heart infusion broth (BHI) before inoculation into experiments. Each test material was made to the desired concentration in either purified water or BHI and autoclaved before use in growth studies. Some of these compounds were not entirely soluble at the desired concentration, but were introduced into experiments as sterilized suspensions.
Test Materials
Two combinations prepared as two-fold concentrates to allow for dilution in experiments, were studied as well as individual components of the combinations.
Combinations were designated as Composition A (D-mannose 4%, potassium carbonate 3%, citric acid 3%, astragalus 0.6%, nettle 0.16%) and Composition B (D-mannose 4%, Polydextrose 2%, Arabinogalactan 0.6%, Fibergum 0.4%, Propolis 0.4%, Dandelion 0.1%).
These compositions are abbreviated respectively as A and B. Where D-mannose is used alone it is abbreviated in text and figures as M and these abbreviations are used consistently throughout.
Growth Studies
Unless otherwise noted, bacterial growth studies to demonstrate inhibition followed the basic pattern of minimal inhibitory concentration determination.
Serial two-fold dilutions of the test article (compound or A or B) were made in BHI in 96 or 48-well plates, inoculated with test bacterium at approximately 1 × Open Journal of Obstetrics and Gynecology 10 4 CFU/ mL, grown at 37˚C overnight and read in a spectrophotometric plate reader at 450 nm with starting absorbance subtracted.
Biofilm
Biofilm studies were conducted in 24-well plate (allowing for 2 mL culture per well). Each well was inoculated heavily with 100 uL of overnight culture of the test bacterium into 2 mL of compound or composition. Plates were sealed with parafilm to retard evaporation and incubated for 7 days at 37˚C.
After development of biofilm, cultures were aspirated and wells washed 3 times with purified water and then 1% safranin [16] was added to each well for 30 minutes to stain the biofilm. The safranin was aspirated and wells washed 3 times with purified water and allowed to dry. Dye was mobilized with alcohol and transferred to a 96-well plate and Abs 562 nm. Absorbance is proportional to biofilm biomass.
Cell Culture
T24 bladder cancer cells [17] were obtained from ATCC and stored in liquid nitrogen until use. They were propagated in 6-well plates with 5 mL of McCoy's medium supplemented with 10% fetal bovine serum at 37˚C in 5% CO 2 . They were grown to confluence prior to infection.
Infections using uropathogens were made at an approximate bacterial concentration of 1 × 10 5 CFU/mL. Infection occurred for 1 hour before aspirating the infected medium and replacement with fresh sterile medium. Cultures were returned to the incubator overnight and supernatant fluids were recovered and sterilized with 0.22 uM syringe filter.
Cytokine Markers
Relative cytokine and chemokine levels in spent T24 cultures were determined by chemiluminescent spot Western blot assays according to the manufacturer's directions (R&D systems).
Quantiation of human inflammatory cytokines and human chemokines em-
ployed the BD diagnostics cytokine bead array systems (cytokine and chemokine tested separately) which was used with the BD Acuri C6 cytometer. The manufacturer's protocol was followed; analysis employed the FCAP software supplied by Becton Dickinson.
Results

Antibacterial Activity
As an initial screen for antimicrobial activity, 1% w:v of each of the compounds was incorporated into BHI medium with 1.5% agar and test organisms were spotted on the surface of the agar. Only citric acid and cranberry provided inhibition and because of the incompatibility of the largely insoluble cranberry powder with subsequent assays, cranberry was not investigated further. Open Journal of Obstetrics and Gynecology
To determine if the compositions noted above had antibacterial activity A and B were prepared in BHI and diluted and inoculated with the test bacteria. D-mannose was a major component in A and B and thus, D-mannose (M) was also included in this experiment. The starting material was prepared as a 2-fold concentrated solution so equal parts inhibitor and BHI would be equivalent to the full-strength inhibitor. The results for each of the test organisms were similar (40% coefficient of variation of absorbance readings between bacterial species) indicating that the Gram negative and Gram positive uropathogens responded similarly to the compositions. Enterococcus showed weaker growth in BHI, so the biggest contributor to the CV was due to this organism; however its trend mirrored the other three uropathogens. These results are presented in Figure 1 .
Of note, under these conditions, M appeared to have some suppression of bacterial growth. The absence of citric acid in B may have contributed to its diminished activity compared to A. Also apparent in this experiment was the dose-response relationship including an effect of D-mannose, which may have been due to high osmolality.
From each of the test conditions a 10uL aliquot of culture was spotted on agar medium and the A composition showed loss of viability, but the B and mannose (M) did not provide a microbicidal effect in 24 hours.
Probiotic and Prebiotic Conditions
A hazard of suppressing bacterial growth of uropathogens either by use of antibiotics or non-antibiotic inhibitors is the potential detrimental effect on probiotic organisms. In this experiment 5 probiotic organisms were challenged with A, B, M and compared to growth in BHI. Again, the compositions were prepared Taken together, these findings suggest that neither A nor B represent a hazard for these probiotic organisms within the context of this in vitro experiment.
While it is useful to know whether probiotic organism growth is stimulated or inhibited in various media, it is more relevant to determine how much probiotic activity they may exert under these conditions. Probiosis may be gauged by growing the probiotic organism under suitable conditions, recovering the supernatant fluid and challenging with a test organism. For A, B and M, Lactobacilli were grown for 48 hours along with BHI without any potential prebiotic additive. The ratio of the test compositions (A, B and M were 9 parts to one part BHI and the BHI control contained 9 parts water to one part BHI. Culture supernatant fluid was filtered to remove bacteria and then challenged with each of the 4 uropathogens. The results obtained are presented in Figure 3 , which indicates the 24 hour growth in the Lactobacillus-conditioned culture supernatants. As with the earlier experiments, the uropathogens showed 
Biofilm
Biofilms are an essential part of pathogenic processes of infectious microorganisms but also a part of the process of stabilizing probiotic populations. Hence the need to understand the effects of potential urinary treatments was applied to both pathogenic and probiotic organisms. were grown in A, B and M. In addition, polydextrose at a concentration equal to that in B was also tested. Again, the additives were prepared double strength and combined with equal volumes of BHI. The result is shown in Figure 5 . In this experiment, B was more supportive of biofilm formation and D-mannose and polydextrose alone did not increase biofilm. An additional observation from this experiment, especially in light of the effect of A on uropathogen biofilm was that biofilm was not decreased by A which suggests that if this were applied in vivo it may be compatible with the beneficial flora. Results from this experiment were based on chemiluminescent signal intensity wherein control membrane signals could be categorized as fold-intensity increase over the control sample. Responses were categorized as indicated in Table   1 and presented as a heat map. From this evaluation, it was immediately clear that a far stronger biomarker response occurred with bacteria versus the compositions or D-mannose. An alternative cytokine assay used a fluorescent detection bead array analyzed by flow cytometry. Because some of the biomarkers detected in the membrane array were also detected in the bead array and the bead array could accommodate more tests, a more extensive evaluation of bacterial infection with and without treatment was undertaken. It was also found that 24 hours of incubation resulted in cytokine levels that were out of range for the bead assay parameter.
Bladder Epithelial Integrity and Reactivity
Thus, bacterial infection occurred for 1 hour followed by 3 washes with fresh medium. Infected and treated cultures were harvested at 4 hours after infection.
Assays were quantitative with results expressed in pg/mL and because of the dynamic range for these assays, results were presented as log pg/mL ( Table 2) . It appeared that many cytokines were high even without infection and this may have been due to the stress of the sham manipulation (3 changes of fresh medium).
This experiment, however suggests there is an opportunity to lower the inflammatory response in the bladder cell culture and suggests that A or B or some of the potentially anti-inflammatory compounds we included in this research could be used in this manner.
A study was conducted to determine if A, B or M could alter the expression of key cytokines in uropathogen-infected T24 cell cultures. Although 6 cytokines were in the bead array panel, TNF, IL12-70p and IL10 were not detected at meaningful levels and are not presented in the results below. Note that because of the smaller range in values, these cytokine concentrations are not presented as log concentrations. After a 1 hour exposure to urinary organisms and 3 washes the results and sampling 6 hours thereafter, bead array data were obtained, assembled and presented below. It is clear, as already discovered, that there is some basal level of cytokine production, especially in the case of IL6 and IL8, which appear even in the absence of infection.
A more significant finding is that A and B have cytokine suppressing effects and the magnitude of these effects in some cases are quite profound. The M effects were somewhat more variable. In Table 3 , cytokine production was most affected for IL6 and IL8 and despite differences in compositions both had effects on cytokines, although IL1-beta showed a somewhat divergent response. Academic and pharmaceutical researchers are continuing to seek non-antibiotic alternatives for treatment and for recurrence prevention. The approaches represent many strategies including immune stimulants, probiotics, adhesion blockers, vaccines, hyperimmune bovine colostrum, estrogen, and modulators of symptoms such as NSAIDS [18] . Popular interest in botanical and other natural products such as cranberry or vitamins attracts public as well as scientific interest [19] .
Discussion
Against this backdrop, two proposed combinations of compounds with putative biological properties that may have relevance to urinary health were studied. We elected to obtain data on these two compositions with the expectation that if interesting biological activities were present, factorial studies could be conducted in a separate and more focused manner. In parallel, some major components of these compositions were investigated independently, specifically M present in both preparations and citric acid which is a major component of A.
The present research was concerned first with the ability of the A and B to inhibit microbial growth with a focus on two Gram negative organisms and two Gram positive organisms. The inhibitory activity discovered was most associated with A and appeared largely derived from citric acid. While the immediate tendency is to attribute inhibitory activity to the acidity of citric acid, a secondary attribute of citric acid is metal chelation. It is not a strong chelator, but synergy with acidity is a consideration. A companion experiment determined whether the compositions had an inhibitory effect on potentially probiotic organisms which, perhaps due to their acid tolerance, were less affected by A.
Relevant to these findings are studies that indicate acid can induce stress responses in microorganisms that increase survival under adverse conditions [20] [21]. This could account for the relative refractoriness of probiotic organisms to A, but should be applicable to E. coli and Enterococcus as well.
Biofilm represents a challenging area for study, because logically if microorganisms are prevented from growing, the production of biofilm is unlikely. Biofilms of pathogens may be detrimental whereas biofilms of probiotic organisms may be beneficial. The experiments here provide evidence for reduced biofilm in uropathogens exposed to B. In the case of probiotic organisms, B supported approximately 20% more biofilm than standard growth medium. While these findings do not indicate that the compositions may be useful clinically, they do not detract from further development.
The third major area of investigation employed bladder epithelial cells and their interactions with bacteria and potential therapeutics. We were able to demonstrate that these cells tolerated exposure to the A and B, but not without some alteration to cellular morphology. Inflammatory and stress cytokines were observed in uninfected bladder epithelial cells but we did not determine the basis for this expression. Possible explanations include the manipulation of the cells (removal from incubation conditions, removing and replacing medium and the possibility that fetal bovine serum in the medium caused some reactivity). An additional feature of the compositions tested was the addition of botanical materials, which may have biological activity as immune modulators. For exam-Open Journal of Obstetrics and Gynecology ple, Astragalus was recently reported to attenuate inflammatory and oxidative stress reactions through the NFkB pathway [22] . Dandelion extract modulates TNF expression induced by LPS [23] and in a recent review [24] nettle is described as having numerous bioactive components with varied activities. These and other individual components may be individually assessed in the bladder epithelial cultures describe here.
The bladder epithelial cultures provided a valuable platform for many potential experiments including, but not limited to, titration of bacterial load, timing of infection, testing different bacterial species and strains with varying displays of virulence factor and factorial evaluation of individual components of the A and B. While the various experimental conditions that might be tested are numerous, the limitation is the cost of cytokine analysis making it necessary to limit the work to the experiments deemed most likely to be informative. Because this research was an exploratory project, not all of the variables were studied, but the results obtained help establish information that suggests how refined and optimized future studies may be carried out. Consideration was given to the possibility that one of the compositions might offer antimicrobial activity and the other might enhance immune or probiotic protection. A better approach for the future may be a single composition incorporating the most beneficial properties of the two compositions. However, this will require additional factorial studies of individual components. A future investigation should approach the matter of a single multipurpose combination.
The overall key findings in this paper suggest that A has antimicrobial activity against uropathogens we tested but is somewhat more aggressive with respect to bladder epithelial cells. B appeared less potent in antimicrobial activity but more supportive of probiotic organisms and having modest modulation of inflammatory activity compared to cell cultures exposed to bacteria.
Apart from the preclinical observations made, it is important to be mindful of the other practical aspects of this work. If the compositions studied are to have clinical relevance, it will be necessary to envision how they could be formulated and how they will be delivered to the site of infection and what the clinical efficacy and tolerability might be. Nevertheless, the work done here establishes a platform on which testing of other potential urinary anti-infective anti-inflammatory compounds or combinations of compounds might be given preliminary evaluation.
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